Pharvaris (PHVS) director Viviane Monges details initial equity holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Pharvaris N.V. director Viviane Monges has filed an initial statement of beneficial ownership detailing her equity position in the company. The filing lists several stock option awards on common stock with exercise prices between 8.0500 and 28.0000 per share and expiration dates running through 2036. It also shows direct ownership of 14,654 shares of common stock and notes restricted stock units granted under the company’s equity plan, including 5,500 RSUs from an award granted March 3, 2026 that will fully vest on March 3, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Monges Viviane
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 16,500 shares (Direct);
Common Stock — 14,654 shares (Direct)
Footnotes (1)
- Includes restricted stock units previously granted under the Company's equity plan that remain outstanding as of March 18, 2026. The awards settle in shares of common stock and are reported in Table I as non-derivative securities. Vesting occurs as follows: -5,500 RSUs from an award granted March 3, 2026 of which 100% will vest March 3, 2027. 100% of the option vest on the 12-month anniversary. 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on July 1, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.
FAQ
What does the Pharvaris (PHVS) Form 3 filed by Viviane Monges show?
The Form 3 shows director Viviane Monges’ initial equity holdings in Pharvaris N.V., including common shares, multiple stock option awards, and restricted stock units that vest over time as part of the company’s equity compensation program.
What stock options does Viviane Monges report in Pharvaris (PHVS)?
Viviane Monges reports several stock option awards on Pharvaris common stock with exercise prices between 8.0500 and 28.0000 per share and expiration dates extending from 2031 to 2036, reflecting long-dated equity incentives as a company director.
What restricted stock units (RSUs) are disclosed for Viviane Monges at Pharvaris (PHVS)?
The footnotes state that her holdings include restricted stock units granted under Pharvaris’ equity plan, including 5,500 RSUs from an award dated March 3, 2026 that are scheduled to vest in full on March 3, 2027.
Are Viviane Monges’ Pharvaris (PHVS) options subject to vesting schedules?
Yes. Footnotes explain that certain option grants vest over time, including awards where 25% vested on specific past dates and the remaining shares vest in 1/48 monthly installments, and one grant where 100% vests on the 12‑month anniversary.